These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28420047)

  • 1. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
    Taraborelli M; Cavazzana I; Martinazzi N; Lazzaroni MG; Fredi M; Andreoli L; Franceschini F; Tincani A
    Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; Egurbide MV; Martinez-Berriotxoa A; Ugalde J; Aguirre C
    Lupus; 2004; 13(12):900-5. PubMed ID: 15645743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.
    Taraborelli M; Leuenberger L; Lazzaroni MG; Martinazzi N; Zhang W; Franceschini F; Salmon J; Tincani A; Erkan D
    Lupus; 2016 Oct; 25(12):1365-8. PubMed ID: 26945023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determinant Factors of Morbidity in Patients with Systemic Lupus Erythematosus].
    Jacinto M; Silva E; Riso N; Moraes-Fontes MF
    Acta Med Port; 2017 May; 30(5):368-372. PubMed ID: 28865500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
    Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC
    Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
    Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
    Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
    Urowitz MB; Gladman DD; Ibañez D; Fortin PR; Bae SC; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Sanchez-Guerrero J; Wallace DJ; Ginzler E; Alarcón GS; Merrill JT; Bruce IN; Sturfelt G; Nived O; Steinsson K; Khamashta M; Petri M; Manzi S; Ramsey-Goldman R; Dooley MA; van Vollenhoven RF; Ramos M; Stoll T; Zoma A; Kalunian K; Aranow C
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):132-7. PubMed ID: 21954226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center.
    El Hadidi KT; Medhat BM; Abdel Baki NM; Abdel Kafy H; Abdelrahaman W; Yousri AY; Attia DH; Eissa M; El Dessouki D; Elgazzar I; Elgengehy FT; El Ghobashy N; El Hadary H; El Mardenly G; El Naggar H; El Nahas AM; El Refai RM; El Rwiny HA; Elsman RM; Galal M; Ghoniem S; Maged LA; Sally SM; Naji H; Saad S; Shaaban M; Sharaf M; Sobhy N; Soliman RM; El Hadidi TS
    Lupus; 2018 May; 27(6):1030-1038. PubMed ID: 29431056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
    Aljohani R; Gladman DD; Su J; Urowitz MB
    Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lupus Foundation of America-Rapid Evaluation of Activity in Lupus Clinician-Reported Outcome Predicts Damage in Patients With Systemic Lupus Erythematosus. Data From the Almenara Lupus Cohort.
    Ugarte-Gil MF; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Pastor-Asurza C; Rodriguez-Bellido Z; Perich-Campos R; Alarcón GS
    J Clin Rheumatol; 2024 Aug; 30(5):e129-e132. PubMed ID: 38880959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
    Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
    Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
    Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
    Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease.
    Nikolopoulos DS; Kostopoulou M; Pieta A; Flouda S; Chavatza K; Banos A; Boletis J; Katsimbri P; Boumpas DT; Fanouriakis A
    Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32601172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.